Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

AKLI | Akili Inc

Index- P/E- EPS (ttm)-0.26 Insider Own49.48% Shs Outstand- Perf Week-15.29%
Market Cap43.70M Forward P/E- EPS next Y-0.68 Insider Trans-0.02% Shs Float39.50M Perf Month-40.92%
Income-8.34M PEG- EPS next Q-0.22 Inst Own38.50% Short Float / Ratio0.30% / 2.63 Perf Quarter-51.38%
Sales0.00M P/S- EPS this Y68.58% Inst Trans20.01% Short Interest0.12M Perf Half Y-64.61%
Book/sh1.06 P/B0.53 EPS next Y16.80% ROA-6.63% Target Price4.00 Perf Year-79.74%
Cash/sh1.36 P/C0.41 EPS next 5Y- ROE-7.08% 52W Range0.53 - 2.76 Perf YTD-50.08%
Dividend- P/FCF- EPS past 5Y- ROI-9.06% 52W High-79.74% Beta1.39
Dividend %- Quick Ratio8.27 Sales past 5Y- Gross Margin- 52W Low6.45% ATR0.10
Employees- Current Ratio8.27 Sales Q/Q- Oper. Margin0.00% RSI (14)26.36 Volatility17.79% 13.45%
OptionableYes Debt/Eq0.21 EPS Q/Q-121.00% Profit Margin- Rel Volume0.99 Prev Close0.55
ShortableYes LT Debt/Eq0.11 EarningsAug 10 AMC Payout- Avg Volume45.64K Price0.56
Recom1.50 SMA20-36.05% SMA50-44.50% SMA200-56.92% Volume17,571 Change1.67%
Date Action Analyst Rating Change Price Target Change
Nov-18-22Initiated BofA Securities Neutral $2
Oct-25-22Initiated Credit Suisse Outperform $5
Sep-06-22Initiated Cowen Outperform
Sep-21-23 08:00AM
Sep-15-23 03:03AM
Sep-13-23 01:16PM
Aug-14-23 09:26AM
06:43AM Loading…
Aug-11-23 06:43AM
Aug-10-23 04:01PM
Jul-10-23 07:00AM
Jun-08-23 01:20PM
Jun-07-23 07:00AM
May-31-23 07:00AM
May-12-23 11:12AM
May-11-23 04:01PM
May-04-23 02:00AM
May-03-23 04:56PM
07:00AM Loading…
Apr-13-23 08:00AM
Mar-13-23 11:51AM
Mar-08-23 08:32AM
Mar-07-23 04:01PM
Feb-08-23 11:37AM
Feb-06-23 07:00AM
Feb-02-23 07:00AM
Jan-06-23 10:43AM
Jan-05-23 07:00AM
Dec-29-22 02:44PM
Dec-27-22 11:05AM
Dec-01-22 07:00AM
Nov-19-22 07:52AM
Nov-10-22 04:01PM
11:53AM Loading…
Nov-01-22 11:53AM
Oct-27-22 07:00AM
Oct-19-22 07:00AM
Sep-21-22 07:00AM
Sep-19-22 07:00AM
Aug-22-22 04:08PM
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its leveraging technologies designed to directly target the brain establishes a new category of medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment. The company is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martucci Walter Edward IIChief Executive OfficerSep 11Sale1.052,3532,4713,150,180Sep 14 08:30 AM
Franklin MatthewPresident & COOSep 11Sale1.051,7281,814753,898Sep 14 08:29 AM
Studer JacquelineChief Legal OfficerSep 11Sale1.051,1301,186348,292Sep 14 08:31 AM
Shanbhag SantoshChief Financial OfficerSep 11Sale1.05830872323,636Sep 14 08:28 AM